The newly established Drive Therapeutics is dedicated to advancing the treatment of retinal diseases through biotechnology. The company's mission is to develop innovative therapies that can address the unmet medical needs of patients suffering from retinal disorders. Drive Therapeutics aims to leverage its expertise in drug discovery and gene therapy to create novel treatments that can improve the quality of life for patients with retinal diseases. With a team of experienced scientists and researchers, the company is well-positioned to make significant contributions to the field of ophthalmology. Stay tuned for updates on Drive Therapeutics' groundbreaking work in this area.